Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 19/20 | 0.53 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.52 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5549587 | 0.83 | F10 (0.53) | F10PRMT5WDR77 | |
| SCHEMBL14497085 | 0.83 | F10 (0.61) | F10 | |
| Hydrochloric Acid SCHEMBL5541384 | 0.82 | F10 (0.60) | F10 | |
| SCHEMBL14496746 | 0.81 | F10 (0.61) | F10 | |
| Hydrochloric Acid SCHEMBL5548162 | 0.80 | F10 (0.60) | F10 | |
| SCHEMBL5548187 | 0.79 | F10 (0.49) | F10PRMT5WDR77 | |
| SCHEMBL5545023 | 0.78 | F10 (0.47) | F10PRMT5WDR77 | |
| SCHEMBL741569 | 0.78 | F10 (0.56) | F10PRMT5WDR77 | |
| SCHEMBL14515121 | 0.77 | F10 (0.66) | F10PRMT5WDR77 | |
| SCHEMBL14496965 | 0.76 | F10 (0.52) | F10PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070129371-A1 | Novel ethylenediamine derivatives | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2007-06-07 | — | — | US | disclosed |
| EP-1577302-A1 | NOVEL ETHYLENEDIAMINE DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2005-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070129371-A1 | Novel ethylenediamine derivatives | C1R, C9, C1S | F10 238/4885PRMT5 1309/4885WDR77 2419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.